DEF: American Healthcare REIT Schedules 2026 Annual Meeting

American Healthcare REIT, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.

Summary

• American Healthcare REIT, Inc. is holding its 2026 Annual Meeting of Stockholders on June 24, 2026, at 8:00 a.m. local time in Irvine, California.
• The meeting agenda includes the election of nine directors, ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026, and an advisory vote on executive compensation for the year ended December 31, 2025.
• Stockholders of record as of April 1, 2026, are entitled to vote.
• The company emphasizes the importance of stockholder participation to ensure a quorum and the successful transaction of business.
• Proxy materials are available online, and stockholders can vote by mail, internet, or telephone.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to the clear communication of upcoming governance events, strong operational performance in 2025, and successful capital raises, despite the temporary leadership change due to medical leave.

Positives

• The company is holding its annual meeting to ensure proper corporate governance and stockholder engagement.
• The board of directors is recommending approval for all proposals, indicating internal alignment.
• The company has a robust board structure with seven independent directors out of nine.
• The Audit Committee includes a designated financial expert, and all members are financially literate.
• The company has a strong corporate responsibility program and is committed to ethical business practices.
• Executive compensation is significantly performance-based and at-risk, with a focus on long-term alignment with stockholder interests.
• The company achieved a 14.2% Same-Store Net Operating Income growth for the twelve months ended December 31, 2025.
• Normalized Funds from Operations attributable to common stockholders increased to $1.72 per diluted share for the twelve months ended December 31, 2025, up from $1.41 in the prior year.
• GAAP net income attributable to common stockholders was $0.42 per diluted share for the twelve months ended December 31, 2025, a significant improvement from a net loss of $0.29 per diluted share in the prior year.
• The company raised $1.5 billion in gross offering proceeds from three public offerings in 2025, strengthening its financial position.
• Net Debt-to-Adjusted EBITDA improved from 4.3x to 3.4x as of December 31, 2025.
• The company was certified as a Great Place to Work for 2025.

Negatives

• Danny Prosky, the CEO and President, is currently on a medical leave of absence, with Jeffrey T. Hanson serving as Interim CEO.
• While GAAP net income improved significantly, the company reported a GAAP net loss attributable to controlling interest of $37.8 million for the twelve months ended December 31, 2024.

Risks

• The filing does not explicitly detail new or emerging risks beyond standard corporate governance and operational considerations.
• The company's reliance on external operators for its senior housing properties could pose risks if those operators underperform or face financial difficulties.

Future Outlook

The filing does not contain specific forward-looking financial guidance but focuses on the upcoming annual meeting agenda and corporate governance matters. The company's performance highlights for 2025, including portfolio growth and improved financial metrics, suggest a positive operational trajectory.

Management Comments

• "Every stockholders vote is important and assists us in establishing the necessary quorum to conduct business at the 2026 Annual Meeting of Stockholders."
• "Regardless of the number of shares of our common stock you own, it is very important that your shares be represented at the 2026 Annual Meeting of Stockholders."
• "We believe that our compensation program for executive officers is an important tool to: Attract, retain and motivate highly-skilled executives; Encourage management to balance short-term goals against longer-term objectives; Achieve an appropriate balance between risk and reward that does not incentivize excessive risk taking; and Align the interests of management and stockholders through the use of equity-based compensation."
• "Our Board of Directors believes that the current structure is appropriate and that, for the reasons set forth below, its existing corporate governance practices achieve independent oversight and management accountability."

Industry Context

StockSavvy.ai notes that this filing is typical for a publicly traded REIT preparing for its annual shareholder meeting. The focus on director elections, auditor ratification, and 'say on pay' reflects standard corporate governance practices. The company's performance metrics, particularly Same-Store NOI growth and Normalized FFO, are key indicators watched by investors in the healthcare real estate sector.

Comparison to Industry Standards

• The company's peer group for executive compensation benchmarking includes major healthcare REITs such as Healthpeak Properties, Inc. and Omega Healthcare Investors, Inc., indicating a focus on aligning executive pay with industry standards for similar-sized companies.
• The Net Debt-to-Adjusted EBITDA ratio of 3.4x as of December 31, 2025, is presented as one of the best among healthcare REIT peers, suggesting strong financial management relative to the industry.
• The company's Same-Store NOI growth of 14.2% for the twelve months ended December 31, 2025, is a strong indicator of operational performance within the healthcare real estate sector, though direct comparisons to specific industry benchmarks would require further data.

Management Changes

Corporate Governance

Related Party Transactions

• Indemnification agreements are in place with all directors and executive officers.
• Lock-up agreements were entered into with directors and executive officers in November 2025, restricting the transfer of shares for a period of one month.

Stakeholder Impact

• Shareholders: The meeting provides an opportunity for shareholders to vote on key corporate matters, including director elections and executive compensation, and to influence company governance.
• Employees: The company highlights its commitment to employees through various programs and benefits, and notes that 73.6% of employees were minorities and 57.9% were female as of December 31, 2025.
• Management: Executive compensation is heavily weighted towards performance-based and equity awards, aligning management interests with long-term shareholder value.

Next Steps

• Stockholders are encouraged to vote their shares for the upcoming Annual Meeting of Stockholders.
• The company will hold its 2026 Annual Meeting of Stockholders on June 24, 2026.
• The company will continue to implement its corporate responsibility program.
• The company will continue to manage its portfolio and pursue strategic acquisitions and dispositions.

Key Dates

Recommendation

The filing is primarily a proxy statement for an annual meeting, detailing standard governance procedures and director nominations. While the company reported strong operational performance for 2025 and successful capital raises, there are no significant new strategic initiatives or financial results that would warrant a strong buy or sell recommendation at this time. The ongoing medical leave of the CEO introduces a minor uncertainty, but the interim leadership and clear governance structure mitigate this risk. Therefore, a 'hold' recommendation is appropriate, pending further strategic updates or financial performance reports.

Keywords

American Healthcare REIT, Proxy Statement, Annual Meeting, Director Election, Executive Compensation, Auditor Ratification, Corporate Governance, REIT, Healthcare Real Estate